Neogen, Illumina sign commercialization agreement

Neogen, Illumina sign commercialization agreement

NEOGEN Corp. announced that it has signed an agreement to expand its relationship with Illumina, a global leader in sequencing and genomics.

Under the agreement, Illumina will market and sell arrays with Neogen's custom single nucleotide polymorphism (SNP) content — built on Illumina Infinium BeadArray technology — to the global agrigenomics community.

Neogen is one of Illumina's largest agrigenomic customers through its Gen

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.